m |
|||
Line 43: | Line 43: | ||
</div> | </div> | ||
</div> | </div> | ||
+ | |||
+ | |||
+ | |||
+ | <div class="contentbox"> | ||
+ | <div class="content"> | ||
+ | <h3> Literature Workshop </h3> | ||
+ | |||
+ | <!-- Normaler Text --> | ||
+ | <article> | ||
+ | Merck is a leading company for products in the pharmaceutical and chemical sectors. Their expertise consists of three mayor sectors: Healthcare, Life Science and Performance Materials. This wide variety of subject areas ensures Mercks status of a global player. Their close collaboration with scientists ensures their high-quality of their products and know-how. Merck has supported the iGEM teams Bielefed-CeBiTec for seven years. We are grateful for their continues scientific support and expertise. | ||
+ | Back in August, we visited Merck to present our final project idea and the first results. Our visit was organized by Prof. Dr. Herget, who has been a great supporter for the iGEM-Teams for Bielefeld for several years. | ||
+ | |||
+ | </article> | ||
+ | |||
+ | <!-- Grosses zentriertes Bild --> | ||
+ | <div class="figure large"> | ||
+ | <img class="figure image" src="https://static.igem.org/mediawiki/2017/0/06/T--Bielefeld-CeBiTec--Merck-Olga-Markus.jpg"> | ||
+ | <p class="figure subtitle"><b>Figure 2: </b><br> iGEM Bielefeld-CeBiTec 2017 team members Olga Schmidt and Markus Haak presenting our project in front of the Merck scientists. </p> | ||
+ | </div> | ||
+ | |||
+ | |||
+ | <article> | ||
+ | |||
+ | The following discussion dealt particularly with possible in vitro and in vivo approaches and the ethical concerns regarding our project. They confirmed our idea to add in vitro experiments as an additional control for our project. | ||
+ | The moral concers have also been addressed. Therefore we designed a survey and asked for second opinions in a variety of meetings with ethicists. This eventuated in our report “ChImp - Chances and Implication of an Expanded Genetic Code”, from which we derive guidelines and recommendations for work awareness in science. | ||
+ | Visiting Merck is valuable in more than just one way: we did not just gain experience in holding a presentation in front of experienced researchers, but also received great advice for the future development of our project. | ||
+ | We are excited to visit Merck again next year to present our final results and the progress we have made. | ||
+ | |||
+ | |||
+ | |||
+ | </article> | ||
+ | |||
+ | <!-- Grosses zentriertes Bild --> | ||
+ | <div class="figure large"> | ||
+ | <img class="figure image" src="https://2017.igem.org/File:T--Bielefeld-CeBiTec--Merck-Gruppenfoto.jpg"> | ||
+ | <p class="figure subtitle"><b>Figure 3: </b><br> iGEM Bielefeld 2017 team members Olga Schmidt and Markus Haak with representatives from the iGEM Bielefeld 2016 team and Merck.</p> | ||
+ | </div> | ||
+ | |||
+ | </div> | ||
+ | </div> | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
Revision as of 15:33, 3 October 2017
Human Practice Silver
Literature Workshop
Figure 1:
Some impressions of our literature workshop.
Literature Workshop
Figure 2:
iGEM Bielefeld-CeBiTec 2017 team members Olga Schmidt and Markus Haak presenting our project in front of the Merck scientists.
Figure 3:
iGEM Bielefeld 2017 team members Olga Schmidt and Markus Haak with representatives from the iGEM Bielefeld 2016 team and Merck.